Forskolin exerts anticancer roles in non-Hodgkin’s lymphomas via regulating Axin/β-catenin signaling pathway

References

• LowryLLinchDNon-Hodgkin’s lymphomaMedicine2013415282289
   Google Scholar
• NewtonRFerlayJBeralVDevesaSSThe epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sitesInt J Cancer19977269239309378552
   PubMed Web of Science ®Google Scholar
• GaoYKristinssonSYGoldinLRBjörkholmMCaporasoNELandgrenOIncreased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial associationGastroenterology20091361919818950631
   PubMed Web of Science ®Google Scholar
• KanneHBurteNPPrasannaVGujjulaRExtraction and elemental analysis of Coleus forskohlii extractPharmacognosy Res20157323724126130934
   PubMedGoogle Scholar
• HendersonSMaguBRasmussenCEffects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight womenJ Int Soc Sports Nutr200522546218500958
   PubMedGoogle Scholar
• LoftusHLAstellKJMathaiMLSuXQColeus forskohlii extract supplementation in conjunction with a hypocaloric diet reduces the risk factors of metabolic syndrome in overweight and obese subjects: a randomized controlled trialNutrients20157119508952226593941
   PubMed Web of Science ®Google Scholar
• GenoveseCDavinelliSManganoKEffects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infectionsJ Chemother201830210711429078739
   PubMed Web of Science ®Google Scholar
• DessauerCWWattsVJOstromRSContiMDoveSSeifertRInternational Union of Basic and Clinical Pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclasesPharmacol Rev20176929313928255005
   PubMed Web of Science ®Google Scholar
• GancedoJMBiological roles of cAMP: variations on a theme in the different kingdoms of lifeBiol Rev Camb Philos Soc201388364566823356492
   PubMed Web of Science ®Google Scholar
• SapioLDi MaioloFIllianoMTargeting protein kinase A in cancer therapy: an updateExcli J20141384385526417307
   PubMed Web of Science ®Google Scholar
• SapioLGalloMIllianoMThe natural cAMP elevating compound forskolin in cancer therapy: is it time?J Cell Physiol2017232592292727739063
   PubMed Web of Science ®Google Scholar
• ParkJYJuhnnYScAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cellsExp Mol Med2017492e29728232663
   PubMedGoogle Scholar
• ZhangLInselPAThe pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cellsJ Biol Chem200427920208582086514996839
   PubMed Web of Science ®Google Scholar
• HayashiTHikichiMYukitakeJForskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cellsOncotarget2018934234512346129805747
   PubMedGoogle Scholar
• Follin-ArbeletVMisundKNaderiEHUglandHSundanABlomhoffHKThe natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BimSci Rep201551300126306624
   PubMed Web of Science ®Google Scholar
• QuinnSNGravesSHDains-McGaheeCAdenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cellsMol Carcinog20175641344136027891679
   PubMed Web of Science ®Google Scholar
• GujralTSKirschnerMWHippo pathway mediates resistance to cytotoxic drugsProc Natl Acad Sci USA201711418E3729E373828416665
   PubMed Web of Science ®Google Scholar
• MohammedMKShaoCWangJWnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistanceGenes Dis201631114027077077
   PubMed Web of Science ®Google Scholar
• McCubreyJAAbramsSLFitzgeraldTLRoles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasisAdv Biol Regul2015577510125453219
   PubMedGoogle Scholar
• KimBHYinCHGuoQA small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cellsMol Cancer Ther2008792672268018790749
   PubMed Web of Science ®Google Scholar
• HientzKMohrABhakta-GuhaDEfferthTThe role of p53 in cancer drug resistance and targeted chemotherapyOncotarget2017858921894627888811
   PubMedGoogle Scholar
• KaradenizCOguzACitakECClinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single centerPediatr Hematol Oncol200724641743017710659
   PubMed Web of Science ®Google Scholar
• AsselinBLDevidasMChenLCardioprotection and safety of dexrazoxane in patients treated for newly diagnosed T-cell acute lymphoblastic leukemia or advanced-stage lymphoblastic non-Hodgkin lymphoma: a report of the Children’s Oncology Group randomized trial Pediatric Oncology Group 9404J Clin Oncol201634885486226700126
   PubMed Web of Science ®Google Scholar
• HuertaMUrzúaZTrujilloXGonzález-SánchezRTrujillo-HernándezBForskolin compared with beclomethasone for prevention of asthma attacks: a single-blind clinical trialJ Int Med Res201038266166820515580
   PubMed Web of Science ®Google Scholar
• Ríos-SilvaMTrujilloXTrujillo-HernándezBEffect of chronic administration of forskolin on glycemia and oxidative stress in rats with and without experimental diabetesInt J Med Sci201411544845224688307
   PubMed Web of Science ®Google Scholar
• WangYTangYHangHcAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistanceAm J Cancer Res201881162929416917
   PubMed Web of Science ®Google Scholar
• PerezDRSmagleyYGarciaMCyclic AMP efflux inhibitors as potential therapeutic agents for leukemiaOncotarget2016723339603398227129155
   PubMedGoogle Scholar
• PattabiramanDRBierieBKoberKIActivation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating abilityScience20163516277)aad368026941323
   PubMed Web of Science ®Google Scholar
• PiontekMHengelsKJPorschenRStrohmeyerGProtein kinase C and adenylate cyclase as targets for growth inhibition of human gastric cancer cellsJ Cancer Res Clin Oncol1993119126976998408180
   PubMed Web of Science ®Google Scholar
• YamanakaHOueTUeharaSFukuzawaMForskolin, a hedgehog signal inhibitor, inhibits cell proliferation and induces apoptosis in pediatric tumor cell linesMol Med Rep20103113313921472212
   PubMed Web of Science ®Google Scholar
• YamanakaHOueTUeharaSFukuzawaMHedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograftJ Pediatr Surg201146232032521292081
   PubMed Web of Science ®Google Scholar
• Amaro-OrtizAYanBD’OrazioJAUltraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulationMolecules20141956202621924838074
   PubMed Web of Science ®Google Scholar
• NusseRCleversHWnt/β-catenin signaling, disease, and emerging therapeutic modalitiesCell2017169698599928575679
   PubMed Web of Science ®Google Scholar
• HoffmeyerKRaggioliARudloffSWnt/β-catenin signaling regulates telomerase in stem cells and cancer cellsScience201233660881549155422723415
   PubMed Web of Science ®Google Scholar
• AnastasJNMoonRTWNT signalling pathways as therapeutic targets in cancerNat Rev Cancer2013131112623258168
   PubMed Web of Science ®Google Scholar
• MacDonaldBTTamaiKHeXWnt/beta-catenin signaling: components, mechanisms, and diseasesDev Cell200917192619619488
   PubMed Web of Science ®Google Scholar
• KimSEHuangHZhaoMWnt stabilization of β-catenin reveals principles for morphogen receptor-scaffold assembliesScience2013340613486787023579495
   PubMed Web of Science ®Google Scholar
• KimJHKimTHKangHSRoJKimHSYoonSSP600125, an inhibitor of JNK pathway, reduces viability of relatively resistant cancer cells to doxorubicinBiochem Biophys Res Commun2009387345045519607816
   PubMed Web of Science ®Google Scholar
• GrassiESVezzoliVNegriISP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on rock and p53 pathwaysOncotarget2015634363833639926415230
   PubMedGoogle Scholar